UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study

BMC psychiatry, 2021-12, Vol.21 (1), p.633-633, Article 633

2021

Link zum Volltext

Verfügbarkeit prüfen

Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?

Frontiers in psychiatry, 2023-05, Vol.14, p.1093081-1093081

2023

Link zum Volltext

Verfügbarkeit prüfen

When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services

Frontiers in psychiatry, 2021-02, Vol.12, p.640222-640222

2021

Link zum Volltext

Verfügbarkeit prüfen

Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia

Frontiers in pharmacology, 2018-10, Vol.9, p.1172-1172

2018

Link zum Volltext

Verfügbarkeit prüfen

Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia

Psychiatry research. Neuroimaging, 2019-05, Vol.287, p.1-9

2019

Link zum Volltext

Verfügbarkeit prüfen

A multiple baseline trial of adapted prolonged exposure psychotherapy for individuals with early phase psychosis, comorbid substance misuse, and a history of adversity: A study protocol

Frontiers in psychology, 2022-12, Vol.13, p.1012776-1012776

2022

Link zum Volltext

Verfügbarkeit prüfen

Distributed Medical Education (DME) in psychiatry: perspectives on facilitators, obstacles, and factors affecting psychiatrists' willingness to engage in teaching activities

BMC medical education, 2024-02, Vol.24 (1), p.192-192, Article 192

2024

Link zum Volltext

Verfügbarkeit prüfen

Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt

Schizophrenia research, 2015-08, Vol.166 (1), p.158-163

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia

Frontiers in pharmacology, 2018-12, Vol.9, p.1417-1417

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic factors contribute to medication-induced QT prolongation: A review

Psychiatry research, 2022-11, Vol.317, p.114891, Article 114891

2022

Link zum Volltext

Verfügbarkeit prüfen

Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC)

JMIR research protocols, 2022-11, Vol.11 (11), p.e40817-e40817

2022

Link zum Volltext

Verfügbarkeit prüfen

The interaction of gender and cannabis in early phase psychosis

Schizophrenia research, 2018-04, Vol.194, p.18-25

2018

Link zum Volltext

Verfügbarkeit prüfen

The role of referral pathway to early intervention services for psychosis on 2-year inpatient and emergency service use

Journal of psychiatric research, 2024-04, Vol.172, p.340-344

2024

Link zum Volltext

Verfügbarkeit prüfen

White matter changes in early phase schizophrenia and cannabis use: An update and systematic review of diffusion tensor imaging studies

Schizophrenia research, 2014-07, Vol.156 (2), p.137-142

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis

The International journal of drug policy, 2021-11, Vol.97, p.103295-103295, Article 103295

2021

Link zum Volltext

Verfügbarkeit prüfen

A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019–21)

Journal of psychiatric research, 2024-05, Vol.173, p.104-110

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data

JAMA psychiatry (Chicago, Ill.), 2021-06, Vol.78 (6), p.667

2021

Link zum Volltext

Verfügbarkeit prüfen

In Response to “Clinical Characteristics Associated With Early Phase Psychosis and Comorbid Substance Use”: Methodological Concerns—Authors’ Reply

Canadian journal of psychiatry, 2023-12, Vol.68 (12), p.949-950

2023

Link zum Volltext

Verfügbarkeit prüfen

MMN and P3a elicited by a novelty paradigm in healthy controls: An investigation of sex differences

Neuroscience letters, 2022-06, Vol.781, p.136654-136654, Article 136654

2022

Link zum Volltext

Verfügbarkeit prüfen

Reduced duration mismatch negativity elicited by the multi-feature ‘optimal’ paradigm in early-phase psychosis

Biological psychology, 2023-05, Vol.180, p.108570-108570, Article 108570

2023

Link zum Volltext

Verfügbarkeit prüfen

Referral pathways to early intervention services for psychosis and their influence on perceptions of care: An interpretive phenomenological analysis

Early intervention in psychiatry, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered

Canadian journal of psychiatry, 2016-06, Vol.61 (6), p.367-372

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of Trauma Cue Exposure and Posttraumatic Stress Disorder (PTSD) on Affect and Cannabis Craving in Cannabis Users With Trauma Histories: Use of Expressive Writing as an Online Cue-Reactivity Paradigm: Effets de l'exposition aux signaux traumatiques et du SSPT sur l'affect et le besoin de cannabis chez les consommateurs de cannabis ayant des antécédents de traumatismes : utilisation de l'écriture expressive comme paradigme de réactivité en ligne

Canadian journal of psychiatry, 2024-05, p.7067437241255104-7067437241255104

2024

Link zum Volltext

Verfügbarkeit prüfen

MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis

Neuropsychobiology, 2022, Vol.81 (6), p.506-515

2022

Link zum Volltext

Verfügbarkeit prüfen

Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis

Journal of psychiatric research, 2023-09, Vol.165, p.77-82

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study

Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?

When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services

Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia

Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia

A multiple baseline trial of adapted prolonged exposure psychotherapy for individuals with early phase psychosis, comorbid substance misuse, and a history of adversity: A study protocol

Distributed Medical Education (DME) in psychiatry: perspectives on facilitators, obstacles, and factors affecting psychiatrists' willingness to engage in teaching activities

Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt

Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia

Genetic factors contribute to medication-induced QT prolongation: A review

Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC)

The interaction of gender and cannabis in early phase psychosis

The role of referral pathway to early intervention services for psychosis on 2-year inpatient and emergency service use

White matter changes in early phase schizophrenia and cannabis use: An update and systematic review of diffusion tensor imaging studies

Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis

A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019–21)

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data

In Response to “Clinical Characteristics Associated With Early Phase Psychosis and Comorbid Substance Use”: Methodological Concerns—Authors’ Reply

MMN and P3a elicited by a novelty paradigm in healthy controls: An investigation of sex differences

Reduced duration mismatch negativity elicited by the multi-feature ‘optimal’ paradigm in early-phase psychosis

Referral pathways to early intervention services for psychosis and their influence on perceptions of care: An interpretive phenomenological analysis

Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered

MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis

Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis

Suchergebnisse filtern